» Articles » PMID: 11208724

Enhancement of Jejunal Absorption of Conjugated Bile Acid by Neurotensin in Rats

Overview
Specialty Gastroenterology
Date 2001 Feb 24
PMID 11208724
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Release of neurotensin (NT) from intestines is markedly stimulated by ingested fat, and NT may facilitate lipid digestion and absorption through various actions that are not fully understood. Our recent finding that NT stimulates hepatic output of bile acids only when bile delivery to the intestine is maintained has led us to investigate the effects of NT on bile acid absorption in the rat small intestine.

Methods: We measured the effects of intravenous infusion of NT (3-10 pmol x kg(-1) x min(-1)) on biliary recovery of (3)H-taurocholate ((3)H-TC) and (3)H-cholate administered into proximal and distal intestines or into isolated intestinal segments in situ in biliary fistula rats. To further understand the underlying mechanisms involved, the effects of NT on intestinal absorption of (3)H-D-glucose, (3)H-leucine, (14)C-antipyrine, and (51)Cr-EDTA were investigated by monitoring the absorption of radioactivity into superior mesenteric venous blood.

Results: Infusion of NT, at doses that caused near physiologic increases in blood NT levels, increased biliary recovery of (3)H-TC from the jejunum (3.4-fold) and ileum (1.7-fold), but did not enhance absorption of (3)H-cholate. NT also facilitated transcellular uptake of (3)H-glucose and (3)H-leucine and increased paracellular uptake to (51)Cr-EDTA and (3)H-mannitol, but did not alter the absorption rate for (14)C-antipyrine.

Conclusions: These results indicate that NT can exert a facilitative effect on intestinal bile acid absorption and return to liver. This effect of NT may involve increases in paracellular absorption and carrier-mediated transport by mechanisms not yet identified.

Citing Articles

RISING STARS: Endocrine regulation of metabolic homeostasis via the intestine and gut microbiome.

Meyer R, Duca F J Endocrinol. 2023; 258(2).

PMID: 37171833 PMC: 10524498. DOI: 10.1530/JOE-23-0019.


Individuals with type 2 diabetes have higher density of small intestinal neurotensin-expressing cells.

Ferreira F, Pereira S, Costa M, Guimaraes M, Wewer Albrechtsen N, Holst J Mol Cell Biochem. 2023; 478(12):2779-2787.

PMID: 36920577 PMC: 10627918. DOI: 10.1007/s11010-023-04698-z.


MiR-203 is an anti-obese microRNA by targeting apical sodium-dependent bile acid transporter.

Liu X, Cheng F, Bai X, Zhao T, Zhao L, Wang L iScience. 2022; 25(8):104708.

PMID: 35856025 PMC: 9287609. DOI: 10.1016/j.isci.2022.104708.


Pro-Neurotensin as a Potential Novel Diagnostic Biomarker for Detection of Nonalcoholic Fatty Liver Disease.

Mohamed A, Abo-Elmatty D, Ezzat O, Mesbah N, Ali N, Abd El Fatah A Diabetes Metab Syndr Obes. 2022; 15:1935-1943.

PMID: 35769889 PMC: 9234179. DOI: 10.2147/DMSO.S365147.


New Insights in the Control of Fat Homeostasis: The Role of Neurotensin.

Barchetta I, Baroni M, Melander O, Cavallo M Int J Mol Sci. 2022; 23(4).

PMID: 35216326 PMC: 8876516. DOI: 10.3390/ijms23042209.